BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26536461)

  • 21. Oroxyloside inhibits angiogenesis through suppressing internalization of VEGFR2/Flk-1 in endothelial cells.
    Zhao K; Li X; Lin B; Yang D; Zhou Y; Li Z; Guo Q; Lu N
    J Cell Physiol; 2018 Apr; 233(4):3454-3464. PubMed ID: 28926106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. cis-[RuCl(BzCN)(bipy)(dppe)]PF6 induces anti-angiogenesis and apoptosis by a mechanism of caspase-dependent involving DNA damage, PARP activation, and Tp53 induction in Ehrlich tumor cells.
    Magalhães LF; Mello-Andrade F; Pires WC; Silva HD; da Silva PFF; Macedo LM; Henrique de Castro C; Carneiro CC; Cardoso CG; de Melo Reis PR; Camargo de Oliveira L; Caetano RR; Batista AA; Silveira-Lacerda EP
    Chem Biol Interact; 2017 Dec; 278():101-113. PubMed ID: 28935426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of auriculasin on vascular endothelial growth factor (VEGF)-induced angiogenesis via regulation of VEGF receptor 2 signaling pathways in vitro and in vivo.
    Cho HD; Moon KD; Park KH; Lee YS; Seo KI
    Food Chem Toxicol; 2018 Nov; 121():612-621. PubMed ID: 30236598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cuprous oxide nanoparticles inhibit angiogenesis via down regulation of VEGFR2 expression.
    Song H; Wang W; Zhao P; Qi Z; Zhao S
    Nanoscale; 2014 Mar; 6(6):3206-16. PubMed ID: 24499922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway.
    Shi J; Lu Y; Wei P
    J Ethnopharmacol; 2016 Aug; 189():230-7. PubMed ID: 27224240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
    Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
    Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation.
    Hsieh MJ; Liu HT; Wang CN; Huang HY; Lin Y; Ko YS; Wang JS; Chang VH; Pang JS
    J Mol Med (Berl); 2017 Mar; 95(3):323-333. PubMed ID: 27847966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mithramycin SK modulates polyploidy and cell death in colon carcinoma cells.
    Bataller M; Méndez C; Salas JA; Portugal J
    Mol Cancer Ther; 2008 Sep; 7(9):2988-97. PubMed ID: 18790779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs.
    Chuang IC; Yang CM; Song TY; Yang NC; Hu ML
    Life Sci; 2015 Oct; 139():52-61. PubMed ID: 26285173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanding the Chemical Diversity of the Antitumoral Compound Mithramycin by Combinatorial Biosynthesis and Biocatalysis: The Quest for Mithralogs with Improved Therapeutic Window.
    Méndez C; González-Sabín J; Morís F; Salas JA
    Planta Med; 2015 Oct; 81(15):1326-38. PubMed ID: 26393942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selenadiazole Derivatives Inhibit Angiogenesis-Mediated Human Breast Tumor Growth by Suppressing the VEGFR2-Mediated ERK and AKT Signaling Pathways.
    Lai H; Fu X; Sang C; Hou L; Feng P; Li X; Chen T
    Chem Asian J; 2018 Jun; 13(11):1447-1457. PubMed ID: 29575811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
    Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
    Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
    Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
    Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPARδ agonists suppress angiogenesis in a VEGFR2-dependent manner.
    Meissner M; Hrgovic I; Doll M; Kaufmann R
    Arch Dermatol Res; 2011 Jan; 303(1):41-7. PubMed ID: 21046127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GABARBP down-regulates HIF-1α expression through the VEGFR-2 and PI3K/mTOR/4E-BP1 pathways.
    Park SH; Kim BR; Lee JH; Park ST; Lee SH; Dong SM; Rho SB
    Cell Signal; 2014 Jul; 26(7):1506-13. PubMed ID: 24686084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and localization of vascular endothelial growth factor A (VEGFA) and its two receptors (VEGFR1/FLT1 and VEGFR2/FLK1/KDR) in the canine corpus luteum and utero-placental compartments during pregnancy and at normal and induced parturition.
    Gram A; Hoffmann B; Boos A; Kowalewski MP
    Gen Comp Endocrinol; 2015 Nov; 223():54-65. PubMed ID: 26414127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-angiogenic and pro-apoptotic effects of a small-molecule JFD-WS in in vitro and breast cancer xenograft mouse models.
    Rathinavelu A; Kanagasabai T; Dhandayuthapani S; Alhazzani K
    Oncol Rep; 2018 Apr; 39(4):1711-1724. PubMed ID: 29436685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leptin-induced transphosphorylation of vascular endothelial growth factor receptor increases Notch and stimulates endothelial cell angiogenic transformation.
    Lanier V; Gillespie C; Leffers M; Daley-Brown D; Milner J; Lipsey C; Webb N; Anderson LM; Newman G; Waltenberger J; Gonzalez-Perez RR
    Int J Biochem Cell Biol; 2016 Oct; 79():139-150. PubMed ID: 27590851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenic potential of human mesenchymal stromal cell and circulating mononuclear cell cocultures is reflected in the expression profiles of proangiogenic factors leading to endothelial cell and pericyte differentiation.
    Joensuu K; Uusitalo-Kylmälä L; Hentunen TA; Heino TJ
    J Tissue Eng Regen Med; 2018 Mar; 12(3):775-783. PubMed ID: 28593699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
    Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
    Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.